The EVP&Pres, Merck Animal Heallth of Merck & Company is Exercising Options
Yesterday it was reported that the EVP&Pres, Merck Animal Heallth of Merck & Company (MRK), Richard Deluca, exercised options to sell 38,126 MRK shares at $39.29 a share, for a total transaction value of $3.24M.
Following Richard Deluca’s last MRK Sell transaction on May 07, 2019, the stock climbed by 8.3%.
See today’s analyst top recommended stocks >>
Based on Merck & Company’s latest earnings report for the quarter ending June 30, the company posted quarterly revenue of $11.68 billion and quarterly net profit of $2.67 billion. In comparison, last year the company earned revenue of $10.34 billion and had a net profit of $1.71 billion. Currently, Merck & Company has an average volume of 6.88M. The Company has a Price to Book ratio of 7.9609.
Based on 6 analyst ratings, the analyst consensus is Strong Buy with an average price target of $94.83, reflecting a 10.6% upside.
Richard Deluca’s trades have generated a -14.9% average return based on past transactions. DailyInsider proprietary algorithm detects trades by the most influential insiders and selects attractive trading opportunities daily. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.